{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:07:39Z","timestamp":1790996859704,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejpb.2024.114432","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T09:29:50Z","timestamp":1722590990000},"page":"114432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Therapeutic targeting of siRNA\/anti-cancer drug delivery system for non-melanoma skin cancer. Part I: Development and gene silencing of JAK1siRNA\/5-FU loaded liposome nanocomplexes"],"prefix":"10.1016","volume":"203","author":[{"given":"Minela","family":"Aslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukru","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Shahbazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Bozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naciye","family":"Dilara Zeybek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130brahim","family":"Vargel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130pek","family":"Ero\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezban","family":"Ulubayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114432_b0005","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1039\/b201025a","article-title":"Climate change and skin cancer","volume":"1","author":"van der Leun","year":"2002","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.ejpb.2024.114432_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines6010006","article-title":"Non melanoma skin cancer pathogenesis overview","volume":"6","author":"Didona","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejpb.2024.114432_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113254","article-title":"European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma\u2014update 2023","volume":"192","author":"Peris","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejpb.2024.114432_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40169-017-0175-0","article-title":"Cancer nanomedicine: a review of recent success in drug delivery","volume":"6","author":"Tran","year":"2017","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejpb.2024.114432_b0025","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2144\/000112792","article-title":"RNAi mechanisms and applications","volume":"44","author":"Kim","year":"2008","journal-title":"Biotechniques"},{"key":"10.1016\/j.ejpb.2024.114432_b0030","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1158\/1078-0432.CCR-07-4839","article-title":"Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers","volume":"14","author":"Jeong","year":"2008","journal-title":"Clin. Cancer Res. an off. J. Am. Assoc Cancer Res."},{"key":"10.1016\/j.ejpb.2024.114432_b0035","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00432-011-1037-6","article-title":"Down-regulation of JAK1 by RNA interference inhibits growth of the lung cancer cell line A549 and interferes with the PI3K\/mTOR pathway","volume":"137","author":"Liu","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2024.114432_b0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neo.2015.01.003","article-title":"JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth","volume":"17","author":"Sen","year":"2015","journal-title":"Neoplasia (united States)"},{"key":"10.1016\/j.ejpb.2024.114432_b0045","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.celrep.2018.10.063","article-title":"Janus Kinase 1 plays a critical role in mammary cancer progression","volume":"25","author":"Wehde","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejpb.2024.114432_b0050","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.2174\/0929867324666170414163937","article-title":"Small molecule drugs and targeted therapy for melanoma: current strategies and future directions","volume":"24","author":"Cerchia","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejpb.2024.114432_b0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/oli.2008.0168","article-title":"Hyaluronic acid-modified DOTAP\/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells","volume":"19","author":"Taetz","year":"2009","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.ejpb.2024.114432_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph13100294","article-title":"Overcoming barriers for siRNA therapeutics: From bench to bedside","volume":"13","author":"Sajid","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejpb.2024.114432_b0065","first-page":"120","article-title":"Epidemiology of skin cancer","volume":"810","author":"Leiter","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejpb.2024.114432_b0070","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.2147\/IJN.S257700","article-title":"Recent advances in designing 5-fluorouracil delivery systems: A stepping stone in the safe treatment of colorectal cancer","volume":"15","author":"Entezar-Almahdi","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2024.114432_b0075","first-page":"1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic, Signal Transduct","volume":"6","author":"Hu","year":"2021","journal-title":"Target. Ther."},{"key":"10.1016\/j.ejpb.2024.114432_b0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-Fluorouracil: Mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejpb.2024.114432_b0085","first-page":"1630","article-title":"Development and characterization of siRNA Lipoplexes: effect of different lipids, in vitro evaluation in cancerous cell lines and in vivo toxicity study","volume":"15","author":"Khatri","year":"2014","journal-title":"Ageing Int."},{"key":"10.1016\/j.ejpb.2024.114432_b0090","first-page":"1502","article-title":"Effective topical delivery systems for corticosteroids: dermatological and histological evaluations","volume":"23","author":"Ero\u011flu","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114432_b0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/08982104.2015.1067892","article-title":"Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: In vitro and in vivo evaluation","volume":"26","author":"Tuncay Tanriverdi","year":"2016","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2024.114432_b0100","first-page":"4637","article-title":"Cationic lipid-coated PEI\/DNA polyplexes with improved efficiency and reduced cytotoxicity for gene delivery into mesenchymal stem cells","volume":"7","author":"Song","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2024.114432_b0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.plasmid.2008.08.003","article-title":"The role of PEI structure and size in the PEI\/liposome-mediated synergism of gene transfection","volume":"61","author":"Hanzl\u00edkov\u00e1","year":"2009","journal-title":"Plasmid"},{"key":"10.1016\/j.ejpb.2024.114432_b0110","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2174\/1567201811666140616160237","article-title":"Preparation and in-vitro transfection efficiency evaluation of modified cationic liposome-polyethyleneimine-plasmid nanocomplexes as a novel gene carrier","volume":"11","author":"Mahmoudi","year":"2014","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114432_b0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/09687680902766716","article-title":"Polyethylenimine of various molecular weights as adjuvant for transfection mediated by cationic liposomes","volume":"26","author":"Penacho","year":"2009","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.ejpb.2024.114432_b0120","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1038\/mtna.2016.8","article-title":"Lipid-based transfection reagents exhibit cryo-induced increase in transfection efficiency","volume":"5","author":"Sork","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejpb.2024.114432_b0125","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1080\/10837450.2020.1803910","article-title":"Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line","volume":"25","author":"Yaman","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2024.114432_b0130","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2217\/nnm-2017-0081","article-title":"Modified gold-based siRNA nanotherapeutics for targeted therapy of triple-negative breast cancer","volume":"12","author":"Shahbazi","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2024.114432_b0135","doi-asserted-by":"crossref","unstructured":"S. Habib, A. Daniels, M. Ariatti, M. Singh, Anti- c-myc cholesterol based lipoplexes as onco- nanotherapeutic agents in vitro, (2021) 1\u201324. doi: 10.12688\/f1000research.25142.2.","DOI":"10.12688\/f1000research.25142.2"},{"key":"10.1016\/j.ejpb.2024.114432_b0140","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2010.11.018","article-title":"Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy","volume":"150","author":"Thomas","year":"2011","journal-title":"J. Control. Release off. J. Control. Release Soc."},{"key":"10.1016\/j.ejpb.2024.114432_b0145","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1208\/s12249-008-9146-5","article-title":"5-Fluorouracil-loaded BSA nanoparticles: formulation optimization and in vitro release study","volume":"9","author":"Maghsoudi","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2024.114432_b0150","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fitote.2013.02.005","article-title":"The inhibition of resveratrol to human skin squamous cell carcinoma A431 xenografts in nude mice","volume":"86","author":"Hao","year":"2013","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejpb.2024.114432_b0155","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/1061186X.2016.1258567","article-title":"Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer","volume":"25","author":"Jose","year":"2017","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2024.114432_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep21881","article-title":"Receptor-targeted liposome-peptide-siRNA nanoparticles represent an efficient delivery system for MRTF silencing in conjunctival fibrosis","volume":"6","author":"Yu-Wai-Man","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2024.114432_b0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/08982104.2019.1630646","article-title":"Liposome-based combination therapy for acne treatment","volume":"30","author":"Ero\u011flu","year":"2020","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2024.114432_b0170","first-page":"244","article-title":"Thin-film hydration preparation method and stability test of DOX-loaded disulfide-linked polyethylene glycol 5000-lysine-di-tocopherol succinate nanomicelles, Asian","volume":"9","author":"Ai","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114432_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114432_b0180","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/21691401.2018.1434533","article-title":"Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy","volume":"46","author":"Haghiralsadat","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ejpb.2024.114432_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics10040193","article-title":"Functional nanoparticles for tumor penetration of therapeutics","volume":"10","author":"Su","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114432_b0190","first-page":"295","article-title":"Nanoparticles as carriers for drug delivery in cancer., Artif. Cells, Nanomedicine","volume":"46","author":"Dadwal","year":"2018","journal-title":"Biotechnol."},{"key":"10.1016\/j.ejpb.2024.114432_b0195","first-page":"1","article-title":"Pathways of cellular internalisation of liposomes delivered siRNA and effects on siRNA engagement with target mRNA and silencing in cancer cells","volume":"8","author":"Alshehri","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2024.114432_b0200","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.biomaterials.2008.04.036","article-title":"Progress in developing cationic vectors for non-viral systemic gene therapy against cancer","volume":"29","author":"Morille","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2024.114432_b0205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jgm.173","article-title":"Polyethylenimine-mediated gene delivery: a mechanistic study","volume":"3","author":"Kichler","year":"2001","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ejpb.2024.114432_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics15041289","article-title":"Multicomponent lipid nanoparticles for RNA transfection","volume":"15","author":"Gretskaya","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114432_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-51065-4","article-title":"Evaluation of novel cationic gene based liposomes with cyclodextrin prepared by thin film hydration and microfluidic systems","volume":"9","author":"Elsana","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2024.114432_b0220","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10616-013-9658-z","article-title":"Salt ions and related parameters affect PEI\u2013DNA particle size and transfection efficiency in Chinese hamster ovary cells","volume":"67","author":"Sang","year":"2015","journal-title":"Cytotechnology"},{"key":"10.1016\/j.ejpb.2024.114432_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics14112520","article-title":"siRNA Functionalized lipid nanoparticles (LNPs) in management of diseases","volume":"14","author":"Kalita","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114432_b0230","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.2147\/IJN.S363990","article-title":"Optimization of lipid nanoformulations for effective mRNA delivery","volume":"17","author":"Chen","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2024.114432_b0235","first-page":"1996","article-title":"DOTAP\/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes","volume":"2015","author":"Kim","year":"1848","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"10.1016\/j.ejpb.2024.114432_b0240","doi-asserted-by":"crossref","first-page":"1488497","DOI":"10.1080\/20022727.2018.1488497","article-title":"Polyethylenimine-based nanocarriers in co-delivery of drug and gene: a developing horizon","volume":"9","author":"Zakeri","year":"2018","journal-title":"Nano Rev. Exp."},{"key":"10.1016\/j.ejpb.2024.114432_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules24203744","article-title":"Biodegradable polymers for gene delivery","volume":"24","author":"Thomas","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2024.114432_b0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0005-2736(03)00027-0","article-title":"Synergistic effect of polyethylenimine and cationic liposomes in nucleic acid delivery to human cancer cells","volume":"1611","author":"Lee","year":"2003","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"10.1016\/j.ejpb.2024.114432_b0255","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejps.2017.03.023","article-title":"Gene transfection efficiency into dendritic cells is influenced by the size of cationic liposomes\/DNA complexes","volume":"102","author":"Inoh","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114432_b0260","first-page":"5367","article-title":"Influence of cationic lipid concentration on properties of lipid\u2013polymer hybrid nanospheres for gene delivery","volume":"10","author":"Bose","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2024.114432_b0265","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nano.2016.08.005","article-title":"Liposome-polyethylenimine complexes (DPPC-PEI lipopolyplexes) for therapeutic siRNA delivery in vivo","volume":"13","author":"Ewe","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2024.114432_b0270","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2012.09.004","article-title":"Crosslinked linear polyethylenimine enhances delivery of DNA to the cytoplasm","volume":"167","author":"Bonner","year":"2013","journal-title":"J. Control. Release off. J. Control. Release Soc."},{"key":"10.1016\/j.ejpb.2024.114432_b0275","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1039\/C8TB00967H","article-title":"The great escape: how cationic polyplexes overcome the endosomal barrier","volume":"6","author":"Bus","year":"2018","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejpb.2024.114432_b0280","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2010.01.035","article-title":"DC-Chol\/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery","volume":"390","author":"Zhang","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114432_b0285","first-page":"371","article-title":"Development of 5-fluorouracil-loaded nano-sized liposomal formulation by two methods: Strategies to enhance encapsulation efficiency of hydrophilic drugs","volume":"25","author":"Yal\u00e7in","year":"2021","journal-title":"J. Res. Pharm."},{"key":"10.1016\/j.ejpb.2024.114432_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/313961","article-title":"5-fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: Evaluation of controlled release kinetics","volume":"2012","author":"Ti\u01e7li Aydin","year":"2012","journal-title":"J. Nanomater."},{"key":"10.1016\/j.ejpb.2024.114432_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12092562","article-title":"The treatment of heterotopic human colon xenograft tumors in mice with 5-fluorouracil attached to magnetic nanoparticles in combination with magnetic hyperthermia is more efficient than either therapy alone","volume":"12","author":"Dabaghi","year":"2020","journal-title":"Cancers (basel)."},{"key":"10.1016\/j.ejpb.2024.114432_b0300","unstructured":"I.C. International Conference on Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH), ICH Official web site\u00a0: ICH, Ich (2021) 1. https:\/\/www.ich.org\/page\/members-observers."},{"key":"10.1016\/j.ejpb.2024.114432_b0305","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.2147\/OTT.S182437","article-title":"SATB1 siRNA-encapsulated immunoliposomes conjugated with CD44 antibodies target and eliminate gastric cancer-initiating cells","volume":"11","author":"Yang","year":"2018","journal-title":"Oncol. Targets. Ther."},{"key":"10.1016\/j.ejpb.2024.114432_b0310","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1039\/c3ra23411h","article-title":"Preparation of liposomes: a novel application of microengineered membranes - Investigation of the process parameters and application to the encapsulation of vitamin e","volume":"3","author":"Laouini","year":"2013","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2024.114432_b0315","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jconrel.2023.09.001","article-title":"Polyethylenimine (PEI) in gene therapy: Current status and clinical applications","volume":"362","author":"Casper","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114432_b0320","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12668-022-00941-x","article-title":"A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents","volume":"12","author":"Andra","year":"2022","journal-title":"Bionanoscience"},{"key":"10.1016\/j.ejpb.2024.114432_b0325","first-page":"381","article-title":"Release stability of 5-fluorouracil liposomal concentrates, gels and lyophilized powder","volume":"62","author":"Mahmoud","year":"2005","journal-title":"Acta Pol. Pharm. - Drug Res."},{"key":"10.1016\/j.ejpb.2024.114432_b0330","first-page":"1","article-title":"Development and stability studies of novel liposomal vancomycin formulations","volume":"2012","author":"Muppidi","year":"2012","journal-title":"ISRN Pharm."},{"key":"10.1016\/j.ejpb.2024.114432_b0335","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.bbamem.2008.04.003","article-title":"Degradation of lyophilized lipid\/DNA complexes during storage: The role of lipid and reactive oxygen species","volume":"1778","author":"Molina","year":"2008","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"10.1016\/j.ejpb.2024.114432_b0340","doi-asserted-by":"crossref","unstructured":"P. Yadava, M. Gibbs, C. Castro, J.A. Hughes, Effect of Lyophilization and freeze-thawing on the stability of siRNA-liposome complexes, 9 (2008) 1-7. doi: 10.1208\/s12249-007-9000-1.","DOI":"10.1208\/s12249-007-9000-1"},{"key":"10.1016\/j.ejpb.2024.114432_b0345","first-page":"305","article-title":"Achieving long-term stability of lipid nanoparticles: Examining the effect of pH, temperature, and lyophilization","volume":"12","author":"Lball","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2024.114432_b0350","first-page":"311","article-title":"In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels","volume":"56","author":"Nounou","year":"2006","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejpb.2024.114432_b0355","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.biopha.2018.09.128","article-title":"A novel 5-Fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes","volume":"108","author":"Handali","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejpb.2024.114432_b0360","first-page":"1498","article-title":"Characterization and evaluation of 5-Fluorouracil-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification technique","volume":"15","author":"Patel","year":"2014","journal-title":"Ageing Int."},{"key":"10.1016\/j.ejpb.2024.114432_b0365","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jsps.2019.02.008","article-title":"The use of chitosan-coated flexible liposomes as a remarkable carrier to enhance the antitumor efficacy of 5-fluorouracil against colorectal cancer","volume":"27","author":"Alomrani","year":"2019","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ejpb.2024.114432_b0370","doi-asserted-by":"crossref","first-page":"e09394","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ejpb.2024.114432_b0375","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.3390\/molecules13102340","article-title":"Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems","volume":"13","author":"Arias","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2024.114432_b0380","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jconrel.2010.09.021","article-title":"Transfer mechanism of temoporfin between liposomal membranes","volume":"150","author":"Hefesha","year":"2011","journal-title":"J. Control. Release off. J. Control. Release Soc."},{"key":"10.1016\/j.ejpb.2024.114432_b0385","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1211\/0022357001777658","article-title":"Sustained release of 5-fluorouracil from polymeric nanoparticles","volume":"52","author":"McCarron","year":"2000","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2024.114432_b0390","unstructured":"A. Jovanovi\u0107, B. Balan\u010d, R. Pravilovi\u0107, A. Ota, N. Ulrih, V. Nedovi\u0107, B. Bugarski, Influence of cholesterol on liposomal membrane fluidity, liposome size and zeta potential, 2017. doi: 10.7251\/EEMSR15011502J."},{"key":"10.1016\/j.ejpb.2024.114432_b0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/326497","article-title":"Liposomes for Use in Gene Delivery","volume":"2011","author":"Balazs","year":"2011","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114432_b0400","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114432_b0405","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1021\/bc500414e","article-title":"Doping hydroxylated cationic lipid into PEGylated cerasome boosts in vivo siRNA transfection efficacy","volume":"25","author":"Li","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejpb.2024.114432_b0410","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.trsl.2019.07.006","article-title":"Efficient nanocarriers of siRNA therapeutics for cancer treatment","volume":"214","author":"Subhan","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejpb.2024.114432_b0415","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijpharm.2008.07.010","article-title":"Hybrid vector including polyethylenimine and cationic lipid, DOTMA, for gene delivery","volume":"363","author":"Matsumoto","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114432_b0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0207558","article-title":"STAT6 knockdown using multiple siRNA sequences inhibits proliferation and induces apoptosis of human colorectal and breast cancer cell lines","volume":"14","author":"Salguero-Aranda","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2024.114432_b0425","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/1061186X.2018.1502775","article-title":"Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex","volume":"27","author":"Hattori","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2024.114432_b0430","first-page":"206","article-title":"Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model., Drug Deliv","volume":"7","author":"Ewe","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejpb.2024.114432_b0435","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.ymthe.2021.02.015","article-title":"Centyrin ligands for extrahepatic delivery of siRNA","volume":"29","author":"Klein","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2024.114432_b0440","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/ecco-jcc\/jjab129","article-title":"Therapeutic siRNAs targeting the JAK\/STAT signalling pathway in inflammatory bowel diseases","volume":"16","author":"Cl\u00e9ment","year":"2022","journal-title":"J. Crohn\u2019s Colitis"},{"key":"10.1016\/j.ejpb.2024.114432_b0445","unstructured":"siRNA Transfection | Transfection Reagents | Cell Lines, In Vivo | Altogen Biosystems, (n.d.). https:\/\/altogen.com\/transfection-resource\/sirna-transfection\/."},{"key":"10.1016\/j.ejpb.2024.114432_b0450","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1093\/nar\/gky145","article-title":"Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides","volume":"46","author":"Wang","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejpb.2024.114432_b0455","article-title":"ERK\/MAPK signalling pathway and tumorigenesis (Review)","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejpb.2024.114432_b0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.835997","article-title":"Digesting the role of JAK-STAT and cytokine signaling in oral and gastric cancers","volume":"13","author":"Ni","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2024.114432_b0465","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0960-9822(09)00445-X","article-title":"Intracellular signalling: putting JAKs on the kinase MAP","volume":"6","author":"Winston","year":"1996","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejpb.2024.114432_b0470","first-page":"1","article-title":"JAK2 inhibitor persistence in MPN: uncovering a central role of ERK activation, Blood","volume":"12","author":"Pandey","year":"2022","journal-title":"Cancer J."},{"key":"10.1016\/j.ejpb.2024.114432_b0475","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/bja\/aeh112","article-title":"Liver tissue partial pressure of oxygen and carbon dioxide during partial hepatectomy","volume":"92","author":"Brooks","year":"2004","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejpb.2024.114432_b0480","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/leu.2011.175","article-title":"The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cells","volume":"25","author":"Monaghan","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.ejpb.2024.114432_b0485","doi-asserted-by":"crossref","unstructured":"Q. Tang, K.Y. Gross, H.H. Fakih, S.O. Jackson, M. Zain U.I. Abideen, K.R. Monopoli, C. Blanchard, C. Bouix-Peter, T. Portal, J.E. Harris, A. Khvorova, J.F. Alterman, Multispecies-targeting siRNAs for the modulation of JAK1 in the skin, Mol. Ther. Nucleic Acids 35 (2024) 1-7. 102117. doi: 10.1016\/j.omtn.2024.102117.","DOI":"10.1016\/j.omtn.2024.102117"},{"key":"10.1016\/j.ejpb.2024.114432_b0490","doi-asserted-by":"crossref","first-page":"143997.1-8","DOI":"10.1016\/j.gene.2019.143997","article-title":"Akt1 and Jak1 siRNA based silencing effects on the proliferation and apoptosis in head and neck squamous cell carcinoma","volume":"714","author":"Vakili Saatloo","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.ejpb.2024.114432_b0495","first-page":"1","article-title":"JAK1 is a novel target of tumor- and invasion-suppressive microRNA 494\u20135p in colorectal cancer","volume":"16","author":"Patil","year":"2024","journal-title":"Cancers (basel)."},{"key":"10.1016\/j.ejpb.2024.114432_b0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-019-0111-4","article-title":"PRSS1 mutation: A possible pathomechanism of pancreatic carcinogenesis and pancreatic cancer","volume":"25","author":"Liu","year":"2019","journal-title":"Mol. Med."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124002583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124002583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T05:19:08Z","timestamp":1730092748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124002583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":100,"alternative-id":["S0939641124002583"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114432","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic targeting of siRNA\/anti-cancer drug delivery system for non-melanoma skin cancer. Part I: Development and gene silencing of JAK1siRNA\/5-FU loaded liposome nanocomplexes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114432"}}